Where does Seaport Therapeutics 's cash flow data come from?

Every line is extracted from Seaport Therapeutics 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

	Q1 '26
Net income	-$25.41M-93.6%
Depreciation and amortization	$26K-27.8%
Stock-based compensation	$2.57M+58.7%
Amortization of debt issuance costs	-$223K+73.3%
Change in accounts payable	$2.78M+239%
Change in other assets	$0-100%
Non-cash operating lease expense	$331K+18.6%
Change in operating lease liabilities	-$323K-40.4%
Net cash from operating activities	-$20.17M+0.2%
Capital expenditures	$0-100%
Purchases of investments	$47.15M-79.1%
Proceeds from maturities/sales of investments	$75M—
Net cash from investing activities	$27.85M+112%
Net cash from financing activities	-$783K—
Effect of exchange rate changes on cash	-$28K—
Net increase (decrease) in cash	$6.87M+103%
Stock-based compensation	$2.57M+58.7%
Non-cash interest expense	-$223K+73.3%
Depreciation	$26K-27.8%
Accounts payable	$2.78M+239%
Increase Decrease In Accrued Expenses And Other Current Liabilities	-$1.5M+19.9%
Increase Decrease In Due To Related Parties Current	$4K+102%
Operating lease liabilities	-$323K-40.4%
Increase Decrease In Prepaid Expenses And Other Current Assets	-$1.57M-159%
Operating lease right-of-use asset amortization	$331K+18.6%
Payment Of Deferred Offering Costs	$783K—
Deferred Offering Costs Included In Accounts Payable And Accrued Expenses	$541K—
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations	-$28K—
Increase Decrease In Operating Lease Liability	-$323K-40.4%
Leased assets obtained in exchange for operating lease liabilities	$584K-47.6%
Free cash flow	-$20.17M+0.4%
Free cash flow	-$20.17M+0.4%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where does Seaport Therapeutics 's cash flow data come from?: Every line is extracted from Seaport Therapeutics 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.